Results: 1-25 | 26-50 | 51-75 | 76-100 | >>

Table of contents of journal: *Clinical nephrology

Results: 1-25/156

Authors: Losito, A Gaburri, M Errico, R Parente, B Cao, PG
Citation: A. Losito et al., Survival of patients with renovascular disease and ACE inhibition, CLIN NEPHR, 52(6), 1999, pp. 339-343

Authors: Brijker, F Magee, CC Tervaert, JWC O'Neill, S Walshe, JJ
Citation: F. Brijker et al., Outcome analysis of patients with vasculitis associated with antineutrophil cytoplasmic antibodies, CLIN NEPHR, 52(6), 1999, pp. 344-351

Authors: Small, G Watson, AR Evans, JHC Gallagher, J
Citation: G. Small et al., Hemolytic uremic syndrome: defining the need for long-term follow-up, CLIN NEPHR, 52(6), 1999, pp. 352-356

Authors: Ikeda, K Ida, O Kimoto, K Takatorige, T Nakanishi, N Tatara, K
Citation: K. Ikeda et al., Effect of early fosfomycin treatment on prevention of hemolytic uremic syndrome accompanying Escherichia coli O157 : H7 infection, CLIN NEPHR, 52(6), 1999, pp. 357-362

Authors: Harmoinen, APT Kouri, TT Wirta, OR Lehtimaki, TJ Rantalaiho, V Turjanmaa, VMH Pasternack, AI
Citation: Apt. Harmoinen et al., Evaluation of plasma cystatin C as a marker for glomerular filtration ratein patients with type 2 diabetes, CLIN NEPHR, 52(6), 1999, pp. 363-370

Authors: Bokenkamp, A Ozden, N Dieterich, C Schumann, G Ehrich, JHH Brodehl, J
Citation: A. Bokenkamp et al., Cystatin C and creatinine after successful kidney transplantation in children, CLIN NEPHR, 52(6), 1999, pp. 371-376

Authors: Tucker, B Fabbian, F Giles, M Johnston, A Baker, LRI
Citation: B. Tucker et al., Reduction of left ventricular mass index with blood pressure reduction in chronic renal failure, CLIN NEPHR, 52(6), 1999, pp. 377-382

Authors: van Ginneken, EEM Assmann, KJM Koolen, MI Jansen, JLJ Wetzels, JFM
Citation: Eem. Van Ginneken et al., Fibrillary-immunotactoid glomerulopathy with renal deposits of IgA lambda:a rare cause of glomerulonephritis, CLIN NEPHR, 52(6), 1999, pp. 383-389

Authors: Wang, JY Chu, P Ko, CT Chiu, CH Lin, YF
Citation: Jy. Wang et al., Pericardial tamponade in chronic dialysis patients: transesophageal echocardiogram during pericardial drainage, CLIN NEPHR, 52(6), 1999, pp. 390-392

Authors: Huber, FX Herzog, L Werle, E Glaser, F
Citation: Fx. Huber et al., Crush syndrome in polytrauma - octreotide in a novel therapeutic concept, CLIN NEPHR, 52(6), 1999, pp. 392-394

Authors: Grcevska, L Polenakovic, M
Citation: L. Grcevska et M. Polenakovic, A long-term follow-up (21 years) of a patient with class III lupus nephritis - complete remission of the renal involvement and death because of CNS involvement, CLIN NEPHR, 52(6), 1999, pp. 394-397

Authors: Kurt, E Manavoglu, O Dilek, K Orhan, B Evrensel, T
Citation: E. Kurt et al., Effect of cisplatin on plasma renin activity and serum aldosterone levels, CLIN NEPHR, 52(6), 1999, pp. 397-398

Authors: Ambuhl, PA Muller, V Binswanger, U
Citation: Pa. Ambuhl et al., Transient proteinuria after infusion of a gelatin plasma volume expander, CLIN NEPHR, 52(6), 1999, pp. 399-400

Authors: Malluche, HH Monier-Faugere, MC
Citation: Hh. Malluche et Mc. Monier-faugere, Understanding and managing hyperphosphatemia in patients with chronic renal disease, CLIN NEPHR, 52(5), 1999, pp. 267-277

Authors: Kondo, S Yoshizawa, N Kusumi, Y Takeuchi, A Torikata, C
Citation: S. Kondo et al., Studies of glomerular permeability factor (GPF) in focal segmental glomerular sclerosis and the relationship between GPF and vascular permeability factor (VPF), CLIN NEPHR, 52(5), 1999, pp. 278-284

Authors: Scholl, U Wastl, U Risler, T Braun, N Grabensee, B Heering, P Schollmeyer, P Zauner, I Stein, G Funfstuck, R Keller, F
Citation: U. Scholl et al., The "point of no return" and the rate of progression in the natural history of IgA nephritis, CLIN NEPHR, 52(5), 1999, pp. 285-292

Authors: Yorioka, N Taniguchi, Y Amimoto, D Ogata, S Sakikubo, E Yamakido, M Naito, T Shimamoto, F
Citation: N. Yorioka et al., Clinicopathological study of myeloperoxidase anti-neutrophil cytoplasmic antibody-associated glomerulonephritis, CLIN NEPHR, 52(5), 1999, pp. 293-296

Authors: Koch, VH Furusawa, EA Saito, MI Colli, A Ignes, EC Okay, Y Junior, DM
Citation: Vh. Koch et al., White coat hypertension in adolescents, CLIN NEPHR, 52(5), 1999, pp. 297-303

Authors: Katzarski, KS Randmaa, I Bergstrom, J
Citation: Ks. Katzarski et al., Influence of hemodialysis on intravascular volume and vasoactive hormones, CLIN NEPHR, 52(5), 1999, pp. 304-311

Authors: Mrowka, C Heintz, B Sieberth, HG
Citation: C. Mrowka et al., Is dialysis membrane type responsible for increased circulating adhesion molecules during chronic hemodialysis?, CLIN NEPHR, 52(5), 1999, pp. 312-321

Authors: Vanuytsel, JL Lins, RL Zachee, P Mattheeussen, J Hosten, S Lens, S Daelemans, R
Citation: Jl. Vanuytsel et al., Comparison of different routes of administration of nadroparin in hemodialysis, CLIN NEPHR, 52(5), 1999, pp. 322-325

Authors: Coyle, JM Kumwenda, MJ Wright, FW
Citation: Jm. Coyle et al., Henoch Schoenlein nephritis, CLIN NEPHR, 52(5), 1999, pp. 326-328

Authors: Kitoh, C Miyagi, K Onoe, T Katano, K Shimada, T Takegoshi, T
Citation: C. Kitoh et al., Reversible peritoneal calcification in a patient treated by CAPD, CLIN NEPHR, 52(5), 1999, pp. 329-332

Authors: Qun, L Luo, Q Zhang, ZY Chen, YC Zhang, JB Dong, H Lin, DH
Citation: L. Qun et al., Effects of astragalus on IL-2/IL-2R system in patients with maintained hemodialysis, CLIN NEPHR, 52(5), 1999, pp. 333-334

Authors: Jorge, C Gil, C Possante, M Catarino, MC Cruz, A Andrade, R Teixeira, R Santos, N Ferreira, A
Citation: C. Jorge et al., Use of a desferrioxamine "microdose" to chelate aluminum in hemodialysis patients, CLIN NEPHR, 52(5), 1999, pp. 335-336
Risultati: 1-25 | 26-50 | 51-75 | 76-100 | >>